薬物スクリーニング実験サービスの世界市場2020–2027:サービス別(職場薬物検査、臨床毒性検査)、サンプル種類別、エンドユーザー別

◆英語タイトル:Drug Screening Laboratory Services Market by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil & Gas, Transportation, Staffing, Government, Other Workplace, Hospital Laboratories, Clinical Laboratories, and Other Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027 by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil & Gas, Transportation, Staffing, Government, Other Workplace, Hospital Laboratories, Clinical Laboratories, and Other Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027
◆商品コード:AMR20SP054
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2020年7月
◆ページ数:220
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,769 ⇒換算¥634,590見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥709,500見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算¥989,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは薬物スクリーニング実験サービスの世界市場について詳細に調査・分析し、イントロダクション、エグゼクティブサマリー、市場概要、サービスタイプ別(職場用薬物検査、臨床毒性検査)分析、サンプル種類別(尿、口腔液、髪、その他)分析、エンドユーザー別(小売、石油・ガス、輸送、スタッフ、政府)分析、地域別分析、企業情報など、今後の市場展望をまとめております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・薬物スクリーニング実験サービスの世界市場規模:サービスタイプ別(職場用薬物検査、臨床毒性検査)
・薬物スクリーニング実験サービスの世界市場規模:サンプル種類別(尿、口腔液、髪、その他)
・薬物スクリーニング実験サービスの世界市場規模:エンドユーザー別(小売、石油・ガス、輸送、スタッフ、政府)
・薬物スクリーニング実験サービスの世界市場規模:地域別
・企業情報
【レポートの概要】

The global drug screening laboratory services market was valued at $6,720.43 million in 2019, and is projected to reach $7,050.91 million by 2027, registering a CAGR of 9.4% from 2020 to 2027.
Drug screening is a quick and painless technical analysis of biological samples such as blood, hair, and urine to diagnose presence of illegal, prescription drugs, or its metabolites. Drug screening devices have improved, owing to the introduction of new technologies that offer users with precise and accurate results. Drug screening tests are adopted by employers to maintain a free, healthy, and sober workforce that helps maintain high productivity and an appropriate work environment. Rise in alcohol consumption among youth & elderly population, increase in use of narcotics & illicit drugs at workplace, and over use of prescribed drugs are the key factors that fuel growth of the drug screening laboratory services market. Moreover, technological advancements in drug screening products, surge in applications of these services, and increase in competition among providers boost growth of the global market. Furthermore, rise in government funding & initiatives for drug testing, increase in patient awareness toward drug screening policies, and adverse effects of drugs & alcohol are other factors that contribute toward growth of the market. However, possible manipulation of drug screening tests, and poor demand in under developed countries are expected to hinder growth of the market.

The drug screening laboratory services market is segmented into service type, sample type, end user, and region. On the basis of service, the market is categorized into workplace drug testing and clinical toxicology. By sample type, it is further divided into urine, oral fluid, breath, hair, and others. On the basis of end user, it is divided into retail, oil & gas, transportation, staffing, government, other workplaces, hospital laboratories, clinical laboratories, and other laboratories. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
 The study provides an in-depth analysis of the global drug screening laboratory services market along with the current trends and future estimations to elucidate the imminent investment pockets.
 A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
 Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
 Extensive analysis of the key segments of the industry helps to understand the application and products of drug screening used across the globe.
 Key market players and their strategies have been analysed to understand the competitive outlook of the drug screening laboratory services market.

KEY MARKET SEGMENTS
By Service Type
• Workplace Drug Testing
• Clinical Toxicology Testing

By Sample Type
• Urine Sample
• Oral Fluid Sample
• Hair Sample
• Others

By End User
• Retail
• Oil and Gas
• Transportation
• Staffing
• Government
• Other Workplaces
• Hospital Laboratories
• Clinical Laboratories
• Other Laboratories

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe

KEY MARKET PLAYERS
• Abbott Laboratories (Alere Inc.)
• Acm Global Laboratories, Inc
• Clinical Reference Laboratory
• Quest Diagnostics Incorporated.
• Laboratory Corporation Of America Holdings
• Psychemedics
• Millennium Health
• Mayo Laboratories For Medical Education and Research
• Omega Laboratories
• Precision Diagnostics
• Cordant Health Solutions

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Porter’s five force analysis
3.3.Key findings

3.3.1.Top Investment Pockets

3.4.Regulations
3.5.Market share analysis
3.6.Market dynamics

3.6.1.Drivers

3.6.1.1.Stringent government regulations regarding drug abuse
3.6.1.2.Rise in awareness against drug abuse
3.6.1.3.Surge in funding for drug screening

3.6.2.Restraints

3.6.2.1.Consideration of drug screening as a violation of rights
3.6.2.2.Negative impact of COVID-19 pandemic on the drug screening market

3.6.3.Opportunities

3.6.3.1.Development of novel drug screening tests
3.6.3.2.Tapping emerging markets

3.7.COVID-19 impact on the market

CHAPTER 4:DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICE TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Workplace drug testing

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Clinical toxicology testing

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

CHAPTER 5:DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Urine

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Oral fluid

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Hair

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.Others

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

CHAPTER 6:DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Retail

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Oil & gas

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Transportation

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

6.5.Staffing

6.5.1.Market size and forecast
6.5.2.Market analysis, by country

6.6.Government

6.6.1.Market size and forecast
6.6.2.Market analysis, by country

6.7.Other workplaces

6.7.1.Market size and forecast
6.7.2.Market analysis, by country

6.8.Hospital laboratories

6.8.1.Market size and forecast
6.8.2.Market analysis, by country

6.9.Clinical laboratories

6.9.1.Market size and forecast
6.9.2.Market analysis, by country

6.10.Other laboratories

6.10.1.Market size and forecast
6.10.2.Market analysis, by country

CHAPTER 7:DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. drug screening laboratory services market, by services
7.2.2.1.2.U.S. drug screening laboratory services market, by sample type
7.2.2.1.3.U.S. drug screening laboratory services market, by end user

7.2.2.2.Canada

7.2.2.2.1.Canada drug screening laboratory services market, by services
7.2.2.2.2.Canada drug screening laboratory services market, by sample type
7.2.2.2.3.Canada drug screening laboratory services market, by end user

7.2.2.3.Mexico

7.2.2.3.1.Mexico drug screening laboratory services market, by services
7.2.2.3.2.Mexico drug screening laboratory services market, by sample type
7.2.2.3.3.Mexico drug screening laboratory services market, by end user

7.2.3.North America market size and forecast, by services
7.2.4.North America market size and forecast, by sample type
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany drug screening laboratory services market, by services
7.3.2.1.2.Germany drug screening laboratory services market, by sample type
7.3.2.1.3.Germany drug screening laboratory services market, by end user

7.3.2.2.France

7.3.2.2.1.France drug screening laboratory services market, by services
7.3.2.2.2.France drug screening laboratory services market, by sample type
7.3.2.2.3.France drug screening laboratory services market, by end user

7.3.2.3.UK

7.3.2.3.1.UK drug screening laboratory services market, by services
7.3.2.3.2.UK drug screening laboratory services market, by sample type
7.3.2.3.3.UK drug screening laboratory services market, by end user

7.3.2.4.Italy

7.3.2.4.1.Italy drug screening laboratory services market, by services
7.3.2.4.2.Italy drug screening laboratory services market, by sample type
7.3.2.4.3.Italy drug screening laboratory services market, by end user

7.3.2.5.Spain

7.3.2.5.1.Spain drug screening laboratory services market, by services
7.3.2.5.2.Spain drug screening laboratory services market, by sample type
7.3.2.5.3.Spain drug screening laboratory services market, by end user

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe drug screening laboratory services market, by services
7.3.2.6.2.Rest of Europe drug screening laboratory services market, by sample type
7.3.2.6.3.Rest of Europe drug screening laboratory services market, by end user

7.3.3.Europe market size and forecast, by services
7.3.4.Europe market size and forecast, by sample type
7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan drug screening laboratory services market, BY SERVICES
7.4.2.1.2.Japan drug screening laboratory services market, by sample type
7.4.2.1.3.Japan drug screening laboratory services market, by end user

7.4.2.2.China

7.4.2.2.1.China drug screening laboratory services market, by services
7.4.2.2.2.China drug screening laboratory services market, by sample type
7.4.2.2.3.China drug screening laboratory services market, by end user

7.4.2.3.Australia

7.4.2.3.1.Australia drug screening laboratory services market, by services
7.4.2.3.2.Australia drug screening laboratory services market, by sample type
7.4.2.3.3.Australia drug screening laboratory services market, by end user

7.4.2.4.India

7.4.2.4.1.India drug screening laboratory services market, by services
7.4.2.4.2.India drug screening laboratory services market, by sample type
7.4.2.4.3.India drug screening laboratory services market, by end user

7.4.2.5.Rest of Asia-Pacific

7.4.2.5.1.Rest of Asia-Pacific drug screening laboratory services market, by services
7.4.2.5.2.Rest of Asia-Pacific drug screening laboratory services market, by sample type
7.4.2.5.3.Rest of Asia-Pacific drug screening laboratory services market, by end user

7.4.3.Asia-Pacific market size and forecast, by services
7.4.4.Asia-Pacific market size and forecast, by sample type
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil drug screening laboratory services market, by services
7.5.2.1.2.Brazil drug screening laboratory services market, by sample type
7.5.2.1.3.Brazil drug screening laboratory services market, by end user

7.5.2.2.South Africa

7.5.2.2.1.South Africa drug screening laboratory services market, by services
7.5.2.2.2.South Africa drug screening laboratory services market, by sample type
7.5.2.2.3.South Africa drug screening laboratory services market, by end user

7.5.2.3.Saudi Arabia

7.5.2.3.1.Saudi Arabia drug screening laboratory services market, by services
7.5.2.3.2.Saudi Arabia drug screening laboratory services market, by sample type
7.5.2.3.3.Saudi Arabia drug screening laboratory services market, by end user

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA drug screening laboratory services market, by services
7.5.2.4.2.Rest of LAMEA drug screening laboratory services market, by sample type
7.5.2.4.3.Rest of LAMEA drug screening laboratory services market, by end user

7.5.3.LAMEA market size and forecast, by services
7.5.4.LAMEA market size and forecast, by sample type
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES (ALERE)

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Business performance

8.2.QUEST DIAGNOSTICS INCORPORATED

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Business performance

8.3.CLINICAL REFERENCE LABORATORY, INC

8.3.1.Company overview
8.3.2.Company snapshot

8.4.LABORATORY CORPORATION OF AMERICA HOLDINGS

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Business performance

8.5.STERLING HEALTHCARE OPCO, LLC/CORDANT HEALTH SOLUTIONS

8.5.1.Company overview
8.5.2.Company snapshot

8.6.ACM GLOBAL LABORATORIES, INC

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Key strategic moves and developments

8.7.OMEGA LABORATORIES LIMITED

8.7.1.Company overview
8.7.2.Company snapshot

8.8.PSYCHEMEDICS CORPORATION

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Business performance
8.8.5.Key strategic moves and developments

8.9.PRECISION DIAGNOSTICS

8.9.1.Company overview
8.9.2.Company snapshot

8.10.MILLENNIUM HEALTH

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Key strategic moves and developments

8.11.MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH

8.11.1.Company overview
8.11.2.Company snapshot

LIST OF TABLES

TABLE 01.DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES TYPE, 2019–2027 ($MILLION)
TABLE 02.DRUG SCREENING LABORATORY SERVICES MARKET FOR WORKPLACE DRUG TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 03.DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL TOXICOLOGY TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 04.DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027 ($MILLION)
TABLE 05.URINE DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.ORAL FLUID DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 07.HAIR DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 08.OTHERS DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 10.DRUG SCREENING LABORATORY SERVICES MARKET FOR RETAIL, BY REGION, 2019–2027 ($MILLION)
TABLE 11.DRUG SCREENING LABORATORY SERVICES MARKET FOR OIL & GAS, BY REGION, 2019–2027 ($MILLION)
TABLE 12.DRUG SCREENING LABORATORY SERVICES MARKET FOR DRUG TESTING LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 13.DRUG SCREENING LABORATORY SERVICES MARKET FOR STAFFING, BY REGION, 2019–2027 ($MILLION)
TABLE 14.DRUG SCREENING LABORATORY SERVICES MARKET FOR GOVERNMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 15.DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER WORKPLACES, BY REGION, 2019–2027 ($MILLION)
TABLE 16.DRUG SCREENING LABORATORY SERVICES MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 17.DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 18.DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 19.DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 21.U.S. DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 22.U.S. DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 23.U.S. DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 24.CANADA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 25.CANADA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 26.CANADA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 27.MEXICO DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 28.MEXICO DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 29.MEXICO DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 30.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 31.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 32.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 33.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 34.GERMANY DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 35.GERMANY DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 36.GERMANY DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 37.FRANCE DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 38.FRANCE DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 39.FRANCE DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 40.UK DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 41.UK DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 42.UK DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 43.ITALY DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 44.ITALY DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 45.ITALY DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 46.SPAIN DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 47.SPAIN DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 48.SPAIN DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 49.REST OF EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 50.REST OF EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 51.REST OF EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 52.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 53.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 54.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 55.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 56.JAPAN DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 57.JAPAN DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 58.JAPAN DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 59.CHINA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 60.CHINA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 61.CHINA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 62.AUSTRALIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 63.AUSTRALIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 64.AUSTRALIA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 65.INDIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 66.INDIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 67.INDIA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 68.REST OF ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 69.REST OF ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 70.REST OF ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 71.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 72.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 73.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 74.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 75.BRAZIL DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 76.BRAZIL DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 77.BRAZIL DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 78.SOUTH AFRICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 79.SOUTH AFRICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 80.SOUTH AFRICA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 81.SAUDI ARABIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 82.SAUDI ARABIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 83.SAUDI ARABIA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 84.REST OF LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 85.REST OF LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 86.REST OF LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 87.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 88.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 89.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 90.ABBOTT: COMPANY SNAPSHOT
TABLE 91.ABBOTT: OERATING SEGMENT
TABLE 92.QUEST DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 93.QUEST DIAGNOSTICS: OPERATING BUSINESS SEGMENTS
TABLE 94.CLINICAL REFERENCE LABORATORY: COMPANY SNAPSHOT
TABLE 95.LABCORP: COMPANY SNAPSHOT
TABLE 96.LABCORP: OPERATING SEGMENTS
TABLE 97.CORDANT: COMPANY SNAPSHOT
TABLE 98.ACM GLOBAL LABORATORIES: COMPANY SNAPSHOT
TABLE 99.OMEGA LABORATORIES: COMPANY SNAPSHOT
TABLE 100.PSYCHEMEDICS: COMPANY SNAPSHOT
TABLE 101.PSYCHEMEDICS: OPERATING SEGMENTS
TABLE 102.PRECISION DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 103.MILLENNIUM HEALTH: COMPANY SNAPSHOT
TABLE 104.MAYO CLINIC LABORATORIES: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 01.GLOBAL DRUG SCREENING MARKET SEGMENTATION
FIGURE 02.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.LOW THREAT OF SUBSTITUTES
FIGURE 05.MODEARTE THREAT OF NEW ENTRANTS
FIGURE 06.HIGH INTENSITY OF RIVALRY
FIGURE 07.TOP INVESTMENT POCKETS
FIGURE 08.MARKET SHARE ANALYSIS, 2019
FIGURE 09.DRIVER, RESTRAINSTS AND OPPORTUNITIES
FIGURE 10.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR WORKPLACE DRUG TESTING, BY COUNTRY, 2019 & 2027(%)
FIGURE 11.DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL TOXICOLOGY TESTING, BY COUNTRY, 2019 &2027 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF URINE DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS ORAL FLUID DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF HAIR DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF OTHERS DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET RETAIL, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR OIL & GAS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR TRANSPORTATION, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR STAFFING, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR GOVERNMENT, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER WORKPLACES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 25.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 26.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 27.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 28.QUEST DIAGNOSTICS: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.QUEST DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 30.LABCORP: REVENUE, 2017–2019 ($MILLION)
FIGURE 31.LABCORP: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 32.LABCORP: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 33.PSYCHEMEDICS: REVENUE, 2017–2019 ($MILLION)
FIGURE 34.PSYCHEMEDICS: NET SALE BY SEGMENT 2019 (%)
FIGURE 35.PSYCHEMEDICS: NET SALE BY REVENUE 2019 (%)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[薬物スクリーニング実験サービスの世界市場2020–2027:サービス別(職場薬物検査、臨床毒性検査)、サンプル種類別、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆